Form 4 for OCGN Ocugen, Inc.
Accepted 2022-10-07 00:00:00 ET · period of report 2022-10-06 · accession 0001062993-22-020658 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-07 | 2022-10-06 | OCGN | Kumar Ramesh | Dir | M - OptEx | $0.51 | +4,500 | 4,500 | New | +$2,295 |
| D | 2022-10-07 | 2022-10-06 | OCGN | Kumar Ramesh | Dir | S - Sale+OE | $1.83 | -4,500 | 0 | -100% | -$8,235 |
| D | 2022-10-07 | 2022-10-06 | OCGN | Kumar Ramesh | Dir | M - OptEx | $0.00 | -4,500 | 4,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-06 | M | A | 4,500 | $0.51 | 4,500 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-06 | S | D | 4,500 | $1.83 | 0 | D | — | — | (F1) This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| 3 | Derivative | Option (Right to Buy) | 2022-10-06 | M | D | 4,500 | $0.00 | 4,500 | D | $0.51 · — to 2030-01-02 | 4,500 Common Stock | (F2) The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. on the applicable vesting dates. |